Rhiannon K Owen1, Simon P Conroy2, Nicholas Taub3, Will Jones4, Daniele Bryden5, Manish Pareek6, Christina Faull1, Keith R Abrams1, Daniel Davis7, Jay Banerjee8. 1. Health Sciences, University of Leicester, Leicester, Leicestershire, UK. 2. Department of Health Sciences, Centre for Medicine University of Leicester, University of Leicester School of Medicine, Leicester LE1 7HA, UK. 3. Department of Health Sciences, University of Leicester, Leicester LE1 6TP, UK. 4. Emergency Department, University Hospitals of Leicester NHS Trust, Leicester, UK. 5. Critical Care, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. 6. Cardiovascular Sciences, University of Leicester, Leicester, UK. 7. MRC Unit for Lifelong Health and Ageing, University College London, London WC1B 5JU, UK. 8. University Hospitals of Leicester NHS Trust, Leicester, UK.
Abstract
BACKGROUND: The aim of this study was to describe outcomes in hospitalised older people with different levels of frailty and COVID-19 infection. METHODS: We undertook a single-centre, retrospective cohort study examining COVID-19-related mortality using electronic health records, for older people (65 and over) with frailty, hospitalised with or without COVID-19 infection. Baseline covariates included demographics, early warning scores, Charlson Comorbidity Indices and frailty (Clinical Frailty Scale, CFS), linked to COVID-19 status. FINDINGS: We analysed outcomes on 1,071 patients with COVID-19 test results (285 (27%) were positive for COVID-19). The mean age at ED arrival was 79.7 and 49.4% were female. All-cause mortality (by 30 days) rose from 9 (not frail) to 33% (severely frail) in the COVID-negative cohort but was around 60% for all frailty categories in the COVID-positive cohort. In adjusted analyses, the hazard ratio for death in those with COVID-19 compared to those without COVID-19 was 7.3 (95% CI: 3.00, 18.0) with age, comorbidities and illness severity making small additional contributions. INTERPRETATION: In this study, frailty measured using the CFS appeared to make little incremental contribution to the hazard of dying in older people hospitalised with COVID-19 infection; illness severity and comorbidity had a modest association with the overall adjusted hazard of death, whereas confirmed COVID-19 infection dominated, with a sevenfold hazard for death.
BACKGROUND: The aim of this study was to describe outcomes in hospitalised older people with different levels of frailty and COVID-19 infection. METHODS: We undertook a single-centre, retrospective cohort study examining COVID-19-related mortality using electronic health records, for older people (65 and over) with frailty, hospitalised with or without COVID-19 infection. Baseline covariates included demographics, early warning scores, Charlson Comorbidity Indices and frailty (Clinical Frailty Scale, CFS), linked to COVID-19 status. FINDINGS: We analysed outcomes on 1,071 patients with COVID-19 test results (285 (27%) were positive for COVID-19). The mean age at ED arrival was 79.7 and 49.4% were female. All-cause mortality (by 30 days) rose from 9 (not frail) to 33% (severely frail) in the COVID-negative cohort but was around 60% for all frailty categories in the COVID-positive cohort. In adjusted analyses, the hazard ratio for death in those with COVID-19 compared to those without COVID-19 was 7.3 (95% CI: 3.00, 18.0) with age, comorbidities and illness severity making small additional contributions. INTERPRETATION: In this study, frailty measured using the CFS appeared to make little incremental contribution to the hazard of dying in older people hospitalised with COVID-19 infection; illness severity and comorbidity had a modest association with the overall adjusted hazard of death, whereas confirmed COVID-19 infection dominated, with a sevenfold hazard for death.
Authors: Theodore D Cosco; John Best; Daniel Davis; Daniele Bryden; Suzanne Arkill; James van Oppen; Indira Riadi; Kevin R Wagner; Simon Conroy Journal: Age Ageing Date: 2021-01-14 Impact factor: 10.668
Authors: Laura C Blomaard; Carolien M J van der Linden; Jessica M van der Bol; Steffy W M Jansen; Harmke A Polinder-Bos; Hanna C Willems; Jan Festen; Dennis G Barten; Anke J Borgers; Jeannet C Bos; Frederiek van den Bos; Esther J M de Brouwer; Floor J A van Deudekom; Suzanne C van Dijk; Mariëlle H Emmelot-Vonk; Raya E S Geels; Esther M M van de Glind; Bas de Groot; Liesbeth Hempenius; Ad M Kamper; Linda M Kampschreur; Marre M M de Koning; Geert Labots; Roy Looman; Jacinta A Lucke; Huub A A M Maas; Francesco U S Mattace-Raso; Rachida El Moussaoui; Barbara C van Munster; Kees van Nieuwkoop; Leanne Ble Oosterwijk; Marlies Em Regtuijt; Sarah H M Robben; Rikje Ruiter; Aisha M Salarbaks; Henrike J Schouten; Orla M Smit; Rosalinde A L Smits; Petra E Spies; Ralph Vreeswijk; Oscar J de Vries; Marjolein A Wijngaarden; Caroline E Wyers; Simon P Mooijaart Journal: Age Ageing Date: 2021-01-30 Impact factor: 10.668
Authors: Amy Miles; Thomas E Webb; Benjamin C Mcloughlin; Imran Mannan; Arshad Rather; Paul Knopp; Daniel Davis Journal: Eur Geriatr Med Date: 2020-07-18 Impact factor: 1.710
Authors: Noemi R Simon; Andrea S Jauslin; Marco Rueegg; Raphael Twerenbold; Maurin Lampart; Stefan Osswald; Stefano Bassetti; Sarah Tschudin-Sutter; Martin Siegemund; Christian H Nickel; Roland Bingisser Journal: J Clin Med Date: 2021-06-02 Impact factor: 4.241
Authors: Flavia Dumitrascu; Karina E Branje; Emily S Hladkowicz; Manoj Lalu; Daniel I McIsaac Journal: J Am Geriatr Soc Date: 2021-06-05 Impact factor: 7.538